Yanina Moglie

Dr. Yanina Moglie

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2016 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
YMYanina Moglie
Yanina Moglie
EMEvangelina Mascaró
Evangelina Mascaró
VGVictoria Gutierrez
Victoria Gutierrez
FAFrancisco Alonso
Francisco Alonso
GRGabriel Radivoy
Gabriel Radivoy

12 January 2022 in RSC Advances
Verified
Journal Article
Open access
PDF file
DRDiego Rodriguez
Diego Rodriguez
YMYanina Moglie
Yanina Moglie
CRCesar A Ramirez-Sarmiento
Cesar A Ramirez-Sarmiento
SSSACHIN Kumar SINGH
SACHIN Kumar SINGH
Kamal DuaKamal Dua
Kamal Dua
FZFlavia Zacconi
Flavia Zacconi
This review summarizes chemo/biocatalytic syntheses that combine the highly efficient click chemistry reactions with the advantages of biocatalysis. The concept of bio-click chemistry and its implications are introduced in this review.

23 January 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Fabián Santana-RomoFabián Santana-Romo
Fabián Santana-Romo
CLCarlos F. Lagos
Carlos F. Lagos
YAYorley Andrea Duarte Ayala
Yorley Andrea Duarte Ayala
FCFrancisco Castillo
Francisco Castillo
YMYanina Moglie
Yanina Moglie
FZFlavia Zacconi
Flavia Zacconi
The coagulation cascade is the process of the conversion of soluble fibrinogen to insoluble fibrin that terminates in production of a clot. Factor Xa (FXa) is a serine protease involved in the blood coagulation cascade. Moreover, FXa plays a vital role in the enzymatic sequence which ends with the thrombus production. Thrombosis is a common causal pathology for three widespread cardiovascular syndromes: acute coronary syndrome (ACS), venous thromboembolism (VTE), and strokes. In this research a series of N-propargyltetrahydroquinoline and 1,2,3-triazole derivatives as a potential factor Xa (FXa) inhibitor were designed, synthesized, and evaluated for their FXa inhibitor activity, cytotoxicity activity and coagulation parameters. Rational design for the desired novel molecules was performed through protein-ligand complexes selection and ligand clustering. The microwave-assisted synthetic strategy of selected compounds was carried out by using Ullmann-Goldberg, N-propargylation, Mannich addition, Friedel-Crafts, and 1,3-dipolar cycloaddition type reactions under microwave irradiation. The microwave methodology proved to be an efficient way to obtain all novel compounds in high yields (73–93%). Furthermore, a thermochemical analysis, optimization and reactivity indexes such as electronic chemical potential (µ), chemical hardness (η), and electrophilicity (ω) were performed to understand the relationship between the structure and the energetic behavior of all the series. Then, in vitro analysis showed that compounds 27, 29–31, and 34 exhibited inhibitory activity against FXa and the corresponding half maximal inhibitory concentration (IC50) values were calculated. Next, a cell viability assay in HEK293 and HepG2 cell lines, and coagulation parameters (anti FXa, Prothrombin time (PT), activated Partial Thromboplastin Time (aPTT)) of the most active novel molecules were performed to determine the corresponding cytotoxicity and possible action on clotting pathways. The obtained results suggest that compounds 27 and 29 inhibited FXa targeting through coagulation factors in the intrinsic and extrinsic pathways. However, compound 34 may target coagulation FXa mainly by the extrinsic and common pathway. Interestingly, the most active compounds in relation to the inhibition activity against FXa and coagulation parameters did not show toxicity at the performed coagulation assay concentrations. Finally, docking studies confirmed the preferential binding mode of N-propargyltetrahydroquinoline and 1,2,3-triazole derivatives inside the active site of FXa.

26 September 2022 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
EBEsteban E. Bjerg
Esteban E. Bjerg
JMJoaquín Marchán-García
Joaquín Marchán-García
EAEduardo Buxaderas Perez de Armiñan
Eduardo Buxaderas Perez de Armiñan
YMYanina Moglie
Yanina Moglie
GRGabriel Radivoy
Gabriel Radivoy

1 April 2018 in Bioorganic Chemistry
Verified
Journal Article
Closed access
VCValeria Cavallaro
Valeria Cavallaro
YMYanina Moglie
Yanina Moglie
Ana Paula MurrayAna Paula Murray
Ana Paula Murray
GRGabriel E. Radivoy
Gabriel E. Radivoy

14 April 2021 in Journal of Materials Chemistry A
Verified
Journal Article
Closed access
PDF file
IMIris Martín-García
Iris Martín-García
GDGloria Díaz-Reyes
Gloria Díaz-Reyes
GSGeorge Sloan
George Sloan
YMYanina Moglie
Yanina Moglie
FAFrancisco Alonso
Francisco Alonso
The stabilisation of metal nanoparticles and control of their oxidation state are crucial factors in nanocatalysis. Elemental sulfur has been found to be a cheap and effective stabilising agent for copper nanoparticles in the form of copper(I) oxide. The Cu2ONPs/S8 system has been characterised by ICP-OES, EDX, XRD, XPS, FE-SEM, SEM, TEM and Cryo-EM. Astonishingly, in organic medium, the copper nanoparticles are organised as concentric rings within nanodroplets of sulfur of ca. 20–70 nm. In synthetic organic chemistry, imines can be directly obtained by the less studied and practiced oxidation of primary amines; however, the reaction conditions utilised are usually harsh and far from meeting the principles of Green Chemistry. Cu2ONPs/S8 has been successfully applied to the solvent-free aerobic oxidation of primary amines to imines under ambient conditions, using air as a terminal oxidant. The catalyst is effective in the homo- and heterocoupling of benzylic amines at very low copper loading (0.3 mol%), being catalytically superior to a range of commercial copper catalysts. A reaction mechanism has been proposed based on experimental evidence, which clarifies the major uncertainty regarding the key intermediate. The results of this study suggest a number of new avenues for research in nanocatalysis.